The board of Ligand Pharmaceuticals (LGND -1.8%) has authorized a $150M increase to its existing $200M stock repurchase program. The expiration date remains September 20, 2021.
As of last week, the company has bought back 745,811 shares for a total of $105.6M.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.